Kite Pharma, Inc., (KITE), today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on June 2, 2015 at 11:00am Eastern Time. The conference will be held in New York, NY.

A live audio webcast of the presentation can be accessed through the Calendar of Events section of the Company’s website at ir.kitepharma.com. A replay of the webcast will be available on the Company’s website for two weeks following the presentation.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT(TM)) designed to restore the immune system’s ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA.

Kite Pharma
Cynthia M. Butitta
Chief Financial Officer and Chief Operating Officer
310-824-9999
For Media: Justin Jackson
For Investor Inquiries: Lisa Burns and Carol Werther
Burns McClellan
212-213-0006
jjackson@burnsmc.com
lburns@burnsmc.com
cwerther@burnsmc.com